Table 3.
Baseline cancer characteristics.
| ILD | Non-ILD | p | |
|---|---|---|---|
| Histology (N, %) | 0.57 | ||
| Adenocarcinoma | 12 (41%) | 172 (47%) | |
| Squamous-cell carcinoma | 9 (31%) | 102 (28%) | |
| Small-cell lung cancer | 6 (21%) | 47 (13%) | |
| Other | 2 (7%) | 42 (12%) | |
| Tumor localization (N, %) | 0.345 | ||
| Upper/middle lobe | 16 (55%) | 224 (63%) | |
| Inferior lobe | 13 (45%) | 133 (37%) | |
| Left lung | 15 (52%) | 164 (46%) | 0.664 |
| Tumor stage (N, %) | 0.067 | ||
| 0 | 0 | 7 (2%) | |
| I | 8 (28%) | 103 (28%) | |
| II | 2 (7%) | 26 (7%) | |
| III | 11 (38%) | 62 (17%) | |
| IV | 8 (28%) | 165 (46%) |
Abbreviations: ILD: interstitial lung disease; p: p value.